• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Matsumura Nagahide  松村 永秀

ORCIDConnect your ORCID iD *help
… Alternative Names

MATSUMURA Nagahide  松村 永秀

Less
Researcher Number 30316103
Affiliation (based on the past Project Information) *help 2016 – 2018: 和歌山県立医科大学, 医学部, 非常勤講師
2012 – 2014: 和歌山県立医科大学, 医学部, 講師
Review Section/Research Field
Principal Investigator
Urology
Except Principal Investigator
Urology
Keywords
Principal Investigator
化学療法 / バイオマーカー / 癌 / 薬学的バイオマーカー / ゲムシタビン / 尿路上皮癌 / 国際情報交換 / 多施設共同研究 / 膀胱癌 / 尿路上皮癌」 … More
Except Principal Investigator
… More 泌尿器科悪性腫瘍 / 免疫寛容 / 泌尿器悪性腫瘍 / 卵巣癌 / 腎細胞癌 / 腫瘍免疫 Less
  • Research Projects

    (3 results)
  • Research Products

    (4 results)
  • Co-Researchers

    (4 People)
  •  The establishment of individualized medicine based on the pharmacological biomarkers in bladder cancer patients treated with gemcitabine-containing combination chemotherapy.Principal Investigator

    • Principal Investigator
      Matsumura Nagahide
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Wakayama Medical University
  •  Establishment of the biomarker in urothelial cancer patients treated with systemic combination chemotherapy.Principal Investigator

    • Principal Investigator
      MATSUMURA Nagahide
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Wakayama Medical University
  •  Development of novel immunotherapy targeting immunosuppressant IDO in urinary tract cancer

    • Principal Investigator
      HARA Isao
    • Project Period (FY)
      2011 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Wakayama Medical University

All 2017 2013 Other

All Journal Article Presentation

  • [Journal Article] Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy.2017

    • Author(s)
      Matsumura Nagahide
    • Journal Title

      International Journal of Urology

      Volume: 24 Issue: 3 Pages: 230-235

    • DOI

      10.1111/iju.13274

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-16K11027
  • [Presentation] 尿路上皮癌に対する化学療法の効果は予測できるか? 効果予測因子としてのバイオマーカーの検討2013

    • Author(s)
      松村永秀
    • Organizer
      日本泌尿器科学会総会
    • Place of Presentation
      札幌
    • Invited
    • Data Source
      KAKENHI-PROJECT-24592407
  • [Presentation] ゲムシタビン併用化学療法を施行した進行性・転移性膀胱癌患者における薬学的バイオマーカー候補物質(hENT1, RRM1, ERCC1)の発現の意義について

    • Author(s)
      松村永秀
    • Organizer
      第100回日本泌尿器科学会総会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-24592407
  • [Presentation] The significance of combined analysis of human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase M1 (RRM1) in advanced bladder cancer patients with gemcitabine-based chemotherapy.

    • Author(s)
      松村永秀
    • Organizer
      107th Annual Meeting of the American Urological Association
    • Place of Presentation
      アトランタ
    • Data Source
      KAKENHI-PROJECT-24592407
  • 1.  HARA Isao (10263378)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 2.  INO Kazuhiko (60303640)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  KODAMA Yoshiki (90347584)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  NAKAMURA Yasushi (60275352)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi